Evaluation of the response rate in major depressive disorder after taking citalopram as a predictive factor base on motor cortex magnetic brain stimulation.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100119003106N43

Enrollment

Registered

2023-02-09

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder. Major depressive disorder, recurrent

Interventions

Intervention 1: Intervention group :48 patients with major depression in the age group of 18 to 65 years will be selected by a psychiatrist or by using the Hamilton and beck questionnaire and the amo

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of major depression by a psychiatrist or by using Hamilton's 24-question questionnaire Age 18-65 years old Having written informed consent and and incentive to cooperate and participate in completing the questionnaires provided by the researcher Not having a history of taking psychiatric drugs in the last 2 weeks

Exclusion criteria

Exclusion criteria: Unwillingness to continue cooperating in the study and not completing the questionnaire If the person is suffering from a specific neurological/psychological disorder at the same time

Design outcomes

Primary

Measure	Time frame
Determining the MEP of patients through TMS. Timepoint: Before taking citalopram and 2 hours after taking citalopram. Method of measurement: Comparison of MEP of patients before and after taking citalopram.	—

Secondary

Measure	Time frame
Hamilton and Beck depression questionnaire. Timepoint: Before taking citalopram and after taking citalopram. Method of measurement: Comparison of Hamilton and beck depression score of patients before and after taking citalopram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKatayoun kiyanipour

Islamic Azad University

Katayun.kiyanipour@gmail.com+98 21 4449 7295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026